日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis

利用脂多糖刺激的骨髓来源树突状细胞进行免疫疗法治疗实验性自身免疫性脑脊髓炎

Zhou, F; Ciric, B; Zhang, G-X; Rostami, A

Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells.

通过慢病毒介导的 CD40 和白细胞介素-23p19 特异性 shRNA 产生的耐受性树突状细胞可以通过抑制 T 辅助细胞 17 型来改善实验性自身免疫性脑脊髓炎

Kalantari T, Karimi M H, Ciric B, Yan Y, Rostami A, Kamali-Sarvestani E

Immunomodulation using the recombinant monoclonal human B7-DC cross-linking antibody rHIgM12.

使用重组单克隆人 B7-DC 交联抗体 rHIgM12 进行免疫调节

Van Keulen V P, Ciric B, Radhakrishnan S, Heckman K L, Mitsunaga Y, Iijima K, Kita H, Rodriguez M, Pease L R

Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis

针对少突胶质细胞的人类单克隆抗体可促进多发性硬化症模型中的髓鞘再生

Warrington, A E; Asakura, K; Bieber, A J; Ciric, B; Van Keulen, V; Kaveri, S V; Kyle, R A; Pease, L R; Rodriguez, M